Posted on 20th November 2011
Scientists in in Australia have just completed a study involving 10,000 patients aged between 50 and 75. Patients taking the drug, fenofibrate, were found to reduce their risk of needing laser treatment (a normal treatment diabetic eye disease) by a third. Fenofibrate is a lipid-modifying agent that helps to reduce complications in diabetic retinopathy. Professor Ian Young from Queen’s University, Belfast who lead the study has urged the National Institute for Clinical Excellence (NICE) to recommend using the drug in the NHS.
08th June 2017
Former managing director and founder of Cameron Optometry, Donald Cameron, attended the International Society of Contact Lens Specialists (ISCLS), along with Ian Cameron. Here Donald shares some of th...Read more
29th May 2017
For patients of the practice, you will know Carol Field, our dispensing practice manager. On Sunday Carol did something amazing. Carol completed the Edinburgh Marathon. The reason this is a particula...Read more